Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Haferkamp

Showing results (91-100 of 149) with videos related to

Pageof 15
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|November 26, 2022
Immune checkpoint inhibition and targeted therapy for melanoma: A patient-oriented cross-sectional comparative multicentre studyAlexander Thiem, Pegah Mashhadiakbar, Christiane Cussigh, et al.
Lancet (London, England)|May 18, 2020
Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): a randomised, double-blind, placebo-controlled, phase 2 trialLisa Zimmer, Elisabeth Livingstone, Jessica C Hassel, et al.
Lancet (London, England)|September 13, 2022
Adjuvant nivolumab plus ipilimumab or nivolumab alone versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): final results of a randomised, double-blind, phase 2 trialElisabeth Livingstone, Lisa Zimmer, Jessica C Hassel, et al.
European Journal of Cancer (Oxford, England : 1990)|January 10, 2021
Robustness of convolutional neural networks in recognition of pigmented skin lesionsRoman C Maron, Sarah Haggenmüller, Christof von Kalle, et al.
Journal for Immunotherapy of Cancer|January 25, 2022
Clinical and molecular characteristics associated with response to therapeutic PD-1/PD-L1 inhibition in advanced Merkel cell carcinomaIvelina Spassova, Selma Ugurel, Linda Kubat, et al.
European Journal of Cancer (Oxford, England : 1990)|August 17, 2019
Systematic outperformance of 112 dermatologists in multiclass skin cancer image classification by convolutional neural networksRoman C Maron, Michael Weichenthal, Jochen S Utikal, et al.
European Journal of Cancer (Oxford, England : 1990)|July 23, 2021
Deep learning approach to predict sentinel lymph node status directly from routine histology of primary melanoma tumoursTitus J Brinker, Lennard Kiehl, Max Schmitt, et al.
Nature Communications|March 5, 2021
Virus-specific memory T cell responses unmasked by immune checkpoint blockade cause hepatitisJames A Hutchinson, Katharina Kronenberg, Paloma Riquelme, et al.
Frontiers in Medicine|May 22, 2020
Effects of Label Noise on Deep Learning-Based Skin Cancer ClassificationAchim Hekler, Jakob N Kather, Eva Krieghoff-Henning, et al.
Cancers|June 2, 2021
Discontinuation of BRAF/MEK-Directed Targeted Therapy after Complete Remission of Metastatic Melanoma-A Retrospective Multicenter ADOReg StudyHenner Stege, Maximilian Haist, Michael Schultheis, et al.
Pageof 15

Showing results (91-100 of 149) with videos related to

Sort By:
Pageof 15
Journal of the European Academy of Dermatology and Venereology : JEADV|November 26, 2022
Immune checkpoint inhibition and targeted therapy for melanoma: A patient-oriented cross-sectional comparative multicentre studyAlexander Thiem, Pegah Mashhadiakbar, Christiane Cussigh, et al.
Lancet (London, England)|May 18, 2020
Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): a randomised, double-blind, placebo-controlled, phase 2 trialLisa Zimmer, Elisabeth Livingstone, Jessica C Hassel, et al.
Lancet (London, England)|September 13, 2022
Adjuvant nivolumab plus ipilimumab or nivolumab alone versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): final results of a randomised, double-blind, phase 2 trialElisabeth Livingstone, Lisa Zimmer, Jessica C Hassel, et al.
European Journal of Cancer (Oxford, England : 1990)|January 10, 2021
Robustness of convolutional neural networks in recognition of pigmented skin lesionsRoman C Maron, Sarah Haggenmüller, Christof von Kalle, et al.
Journal for Immunotherapy of Cancer|January 25, 2022
Clinical and molecular characteristics associated with response to therapeutic PD-1/PD-L1 inhibition in advanced Merkel cell carcinomaIvelina Spassova, Selma Ugurel, Linda Kubat, et al.
European Journal of Cancer (Oxford, England : 1990)|August 17, 2019
Systematic outperformance of 112 dermatologists in multiclass skin cancer image classification by convolutional neural networksRoman C Maron, Michael Weichenthal, Jochen S Utikal, et al.
European Journal of Cancer (Oxford, England : 1990)|July 23, 2021
Deep learning approach to predict sentinel lymph node status directly from routine histology of primary melanoma tumoursTitus J Brinker, Lennard Kiehl, Max Schmitt, et al.
Nature Communications|March 5, 2021
Virus-specific memory T cell responses unmasked by immune checkpoint blockade cause hepatitisJames A Hutchinson, Katharina Kronenberg, Paloma Riquelme, et al.
Frontiers in Medicine|May 22, 2020
Effects of Label Noise on Deep Learning-Based Skin Cancer ClassificationAchim Hekler, Jakob N Kather, Eva Krieghoff-Henning, et al.
Cancers|June 2, 2021
Discontinuation of BRAF/MEK-Directed Targeted Therapy after Complete Remission of Metastatic Melanoma-A Retrospective Multicenter ADOReg StudyHenner Stege, Maximilian Haist, Michael Schultheis, et al.
Pageof 15